FDA Issues Draft Guidance Regarding the Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications

more+
less-

On April 17, 2009, the FDA issued a Draft Guidance for Industry titled Submission of Summary Bioequivalence Data for ANDAs. The draft guidance provides information for applicants submitting bioequivalence studies.

Please see full alert for more information.

LOADING PDF: If there are any problems, click here to download the file.